3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (23) , 6049-6053
- https://doi.org/10.1016/j.bmcl.2006.08.118
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSPBioorganic & Medicinal Chemistry Letters, 2006
- Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verificationBioorganic & Medicinal Chemistry, 2006
- DNA damage checkpoints in mammalsMutagenesis, 2005
- Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitorsBiochemical Journal, 2005
- The Crystal Structure of Human CDK7 and Its Protein Recognition PropertiesStructure, 2004
- Targeting the checkpoint kinases: chemosensitization versus chemoprotectionNature Reviews Cancer, 2004
- Implications for Chk1 Regulation: The 1.7 Å Crystal Structure of Human Cell Cycle Checkpoint Kinase Chk1Cell, 2000
- A novel cyclin associates with M015/CDK7 to form the CDK-activating kinaseCell, 1994
- The Entropic Cost of Bound Water in Crystals and BiomoleculesScience, 1994
- Phase transfer catalyzed synthesis of indazoles from o‐alkylbenzenediazonium tetrafluoroboratesJournal of Heterocyclic Chemistry, 1984